Energy metabolism in ALS: an underappreciated opportunity?

Tijs Vandoorne,Katrien De Bock,Ludo Van Den Bosch

DOI: https://doi.org/10.1007/s00401-018-1835-x

IF: 15.887

2018-03-16

Acta Neuropathologica

Abstract:Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive and fatal neurodegenerative disorder that primarily affects motor neurons. Despite our increased understanding of the genetic factors contributing to ALS, no effective treatment is available. A growing body of evidence shows disturbances in energy metabolism in ALS. Moreover, the remarkable vulnerability of motor neurons to ATP depletion has become increasingly clear. Here, we review metabolic alterations present in ALS patients and models, discuss the selective vulnerability of motor neurons to energetic stress, and provide an overview of tested and emerging metabolic approaches to treat ALS. We believe that a further understanding of the metabolic biology of ALS can lead to the identification of novel therapeutic targets.

pathology,neurosciences,clinical neurology